주식회사 큐리언트;재단법인 한국파스퇴르연구소;INSTITUT PASTEUR KOREA;JUSIKHOESA QUROSCIENCE
发明人:
NO, ZAE SUNG,노재성,KIM, JAE SEONG,김재성,HAN, SEONG JUN,한성준,KIM, JEONG HWAN,김정환,PARK, YOUNG SAM,박영삼,LEE, SANG CHUL,이상출,NAM, KI YEAN,남기연,KIM, JEONG JUN,김정준,LEE, JIN HWA,이진화,KANG, SUN HEE,강선희,SEO, MIN JUNG,서,NO, ZAE SUNGKR,KIM, JAE SEONGKR,HAN, SEONG JUNKR,KIM, JEONG HWANKR,PARK, YOUNG SAMKR,LEE, SANG CHULKR,NAM, KI YEANKR,KIM, JEONG JUNKR,LEE, JIN HWAKR,KANG, SUN HEEKR
申请号：
KR1020137030621
公开号：
KR1020140093610A
申请日:
2012.04.20
申请国别(地区):
KR
年份:
2014
代理人:
摘要：
The present invention relates to small molecule compounds and use thereof for treating inflammatory diseases, especially asthma, chronic obstructive pulmonary disease (COPD), inflammation after infection, arthritis, atherosclerosis, schmerz, and dermatitis. In one aspect, the present invention relates to a compound, which is presented by chemical formula I and is used for treating inflammatory diseases, and pharmaceutically acceptable salts thereof. The purpose of the present invention is identifying a compound having an effect of inhibiting arachidonate 5-lipoxygenase.본 발명은 소분자 화합물 및 염증성 질환, 특히 천식, 만성 폐쇄성 폐질환(COPD), 감염후 염증, 관절염, 죽상동맥경화증, 동통 및 피부염의 치료에 있어서의 이들의 용도에 관한 것이다.
